Lindmed Trade, S.L Pharmaceutical Import Profile — Spain (DGFT 2022–2026)

Name: Lindmed Trade, S.L Pharmaceutical Import Records from India — 2 Products, $400.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Lindmed Trade, S.L — Pharmaceutical Importer Profile (2026) | 2 Products, $400.0K Trade | TransData Nexus

Lindmed Trade, S.L

Pharmaceutical Importer · Spain · Medical Devices & Diagnostics Focus · $400.0K Total Trade · DGFT Verified

Lindmed Trade, S.L is a pharmaceutical importer based in Spain with a total trade value of $400.0K across 2 products in 2 therapeutic categories. Based on 8 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Lindmed Trade, S.L sources from 2 verified Indian suppliers, with Virchow Biotech Private Limited accounting for 89.8% of imports.

Lindmed Trade, S.L — Import Portfolio & Supplier Network

Lindmed Trade, S.L import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Lindmed Trade, S.L?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Virchow Biotech Private Limited	$250.0K	5	89.8%
Globela Pharma Private Limited	$28.3K	3	10.2%

Lindmed Trade, S.L sources from 2 verified Indian suppliers across .

What Formulations Does Lindmed Trade, S.L Import?

Formulation	Value	Ships
Enaxoparin 60MG prefilled	$250.0K	5
Glomatinib 400( spain) ih imatinib tablets 400MG-batch no.gst23169-mfg.dt.10/2023-exp.	$14.9K	1
Glourea 500 (Pack 10x10's) (hydroxyureacapsules USP 500 MG) (batch no gsc23113mfg dt 10/2023 exp dt 09/2026	$8.8K	1
Glourea 500 (Pack 10x10's) (hydroxyureacapsules USP 500 MG) (batch no gsc23114mfg dt 10/2023 exp dt 09/2026	$4.5K	1

Lindmed Trade, S.L imports 4 distinct pharmaceutical formulations. Showing top 4 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Syringe	Medical Devices & Diagnostics	$250.0K	5	0.1%	20
2	Enoxaparin	Cardiovascular	$150.0K	3	0.1%	18

Lindmed Trade, S.L imports 2 pharmaceutical products across 2 categories into Spain totaling $400.0K.

Lindmed Trade, S.L — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Lindmed Trade, S.L. is a Spanish pharmaceutical importer and buyer specializing in the acquisition of finished pharmaceutical formulations from international suppliers. Established as a Sociedad Limitada (S.L.), the company is headquartered at Calle Apolonio Morales 10, 28036 Madrid, Spain. The firm's primary focus is on sourcing and importing pharmaceutical products, including syringes and enoxaparin, to meet the demands of the Spanish healthcare market.

In the period from 2022 to 2026, Lindmed Trade, S.L. has imported a total of $400,000 USD worth of pharmaceutical products from India, comprising eight shipments. The product portfolio includes two main items: syringes and enoxaparin, categorized under medical devices and diagnostics, and cardiovascular therapeutic areas, respectively. The company's operations are characterized by a high degree of supplier concentration, with 89.8% of imports sourced from VIRCHOW BIOTECH PRIVATE LIMITED and 10.2% from GLOBELA PHARMA PRIVATE LIMITED.

2Distribution Network

While specific details regarding Lindmed Trade, S.L.'s warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic position in Madrid suggests a centralized distribution model. This centralization likely facilitates efficient access to Spain's extensive transportation infrastructure, including major ports and airports, enabling effective distribution across the country. The firm's focus on importing finished pharmaceutical formulations indicates a streamlined supply chain designed to meet the needs of Spanish healthcare providers promptly.

3Industry Role

Lindmed Trade, S.L. operates as a pharmaceutical importer and buyer within Spain's healthcare supply chain. By sourcing finished pharmaceutical formulations from international suppliers, the company plays a crucial role in ensuring the availability of essential medical products in the Spanish market. Its activities support the operations of hospitals, clinics, and pharmacies by providing access to specialized medical devices and cardiovascular medications.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Lindmed Trade, S.L

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The sourcing strategy of Lindmed Trade, S.L. exhibits a significant concentration, with 89.8% of its imports originating from VIRCHOW BIOTECH PRIVATE LIMITED and 10.2% from GLOBELA PHARMA PRIVATE LIMITED. This single-source dependency may pose risks related to supply chain disruptions, such as production delays or quality control issues. However, the company's consistent import patterns over the years suggest a stable and reliable relationship with these suppliers, indicating that the concentration is likely a strategic choice to maintain product quality and supply consistency.

2Supply Chain Resilience

Lindmed Trade, S.L.'s supply chain resilience appears to be robust, given the consistent sourcing from two primary suppliers. The firm's focus on importing finished pharmaceutical formulations suggests a streamlined supply chain designed to meet the needs of Spanish healthcare providers promptly. However, the limited number of suppliers may expose the company to risks associated with supplier-specific issues. The company's strategic location in Madrid provides access to Spain's extensive transportation infrastructure, including major ports and airports, which can mitigate potential disruptions.

3Strategic Implications

Importing Pharmaceuticals into Spain — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Spain

1Regulatory Authority & Framework

In Spain, the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) is the primary regulatory authority overseeing the pharmaceutical sector. The AEMPS is responsible for ensuring the quality, safety, and efficacy of medicinal products and medical devices available in Spain. Key legislation governing pharmaceutical imports includes the Spanish Medicines Act and the Royal Decree on the Importation of Medicinal Products. For Indian generics to be marketed in Spain, they must undergo a centralized marketing authorization process through the European Medicines Agency (EMA), which evaluates the scientific data to ensure compliance with EU standards.

2Import Licensing & GMP

Importers like Lindmed Trade, S.L. must obtain an import license from the AEMPS to legally bring pharmaceutical products into Spain. Additionally, the imported products must be manufactured in facilities that comply with Good Manufacturing Practice (GMP) standards recognized by the European Union, such as EU GMP, WHO GMP, or PIC/S certifications. These certifications ensure that the products meet the required quality standards. Importers must also hold a wholesale distribution authorization from the AEMPS to distribute pharmaceutical products within Spain.

Quality & Labeling

Lindmed Trade, S.L — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Lindmed Trade, S.L.'s focus on importing syringes and enoxaparin indicates a strategic emphasis on essential medical devices and cardiovascular medications. The demand for these products in Spain is driven by the need for reliable and effective medical supplies in hospitals and clinics. By concentrating on these therapeutic areas, Lindmed Trade, S.L. aims to meet critical healthcare needs and establish a strong presence in the Spanish pharmaceutical market.

2Sourcing Profile

Lindmed Trade, S.L. primarily sources generic pharmaceutical products from India, focusing on finished formulations such as syringes and enoxaparin. This strategy allows the company to offer cost-effective solutions to the Spanish healthcare sector while maintaining product quality. India's established reputation in pharmaceutical manufacturing, particularly for generics, aligns with Lindmed Trade, S.L.'s sourcing objectives.

3Market Positioning

Based on its product mix, Lindmed Trade, S.L. serves the wholesale distribution segment of the Spanish pharmaceutical market. By importing essential medical devices and cardiovascular medications, the company supplies hospitals, clinics, and pharmacies with critical healthcare products, supporting the overall healthcare infrastructure in Spain.

Seller's Guide — How to Become a Supplier to Lindmed Trade, S.L

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Lindmed Trade, S.L., especially if they can provide products that complement the company's existing portfolio. Potential gaps in Lindmed Trade, S.L.'s current sourcing include a broader range of medical devices or other therapeutic areas that are in demand in Spain. Indian exporters can explore these opportunities by aligning their product offerings with the needs of Lindmed Trade, S.L. and the Spanish market.

2Requirements & Qualifications

Indian exporters seeking to supply Lindmed Trade, S.L. and the Spanish market must ensure that their products are manufactured in facilities with GMP certifications recognized by the European Union, such as EU GMP, WHO GMP, or PIC/S. Products must also comply with Spanish labeling requirements, including Spanish language labeling and serialization mandates. Additionally, exporters should be prepared to navigate the marketing authorization process through the EMA to ensure that their products meet the necessary standards for the Spanish market.

3How to Approach

Frequently Asked Questions — Lindmed Trade, S.L

What products does Lindmed Trade, S.L import from India?

Lindmed Trade, S.L imports 2 pharmaceutical products across 2 categories. Top imports: Syringe ($250.0K), Enoxaparin ($150.0K).

Who supplies pharmaceuticals to Lindmed Trade, S.L from India?

Lindmed Trade, S.L sources from 2 verified Indian suppliers. The primary supplier is Virchow Biotech Private Limited (89.8% of imports, $250.0K).

What is Lindmed Trade, S.L's total pharmaceutical import value?

Lindmed Trade, S.L's total pharmaceutical import value from India is $400.0K, based on 8 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Lindmed Trade, S.L focus on?

Lindmed Trade, S.L imports across 2 categories. The largest: Medical Devices & Diagnostics (62.5%), Cardiovascular (37.5%).

Get Full Lindmed Trade, S.L Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.